SWISS BRIDGE Award to support lung cancer research

Cancer is predicted to affect one in three people in their lifetime. While treatment options are growing, widespread tumour resistance to treatment begs for more research into fundamental mechanisms and rational combination therapies. The prestigious SWISS BRIDGE Award will now support IMP senior group leader Anna Obenauf’s research into resistance mechanisms in lung cancer.